# Waters Corporation Announces $17.5 Billion Merger with BD's Biosciences and Diagnostic Solutions Business

> ma · REPORTED · 2025-07-01

Waters Corporation agreed in July 2025 to combine with BD's Biosciences and Diagnostic Solutions business in a Reverse Morris Trust transaction valued at approximately $17.5 billion, doubling Waters' addressable market to around $40 billion and targeting $345 million in synergies by 2030. The deal reshapes the life-science tools landscape by pairing Waters' liquid chromatography and mass spectrometry strength with BD's broad regulated testing solutions portfolio.

About Waters Corporation / BD Biosciences: Waters Corporation is a publicly listed analytical technologies company specializing in liquid chromatography and mass spectrometry instruments and software; BD Biosciences and Diagnostic Solutions provides cell analysis, flow cytometry, and diagnostic platforms used across academic, biopharma, and clinical laboratory settings.

- Company: Waters Corporation / BD Biosciences
- Sector: life-science tools
- Primary source: https://www.grandviewresearch.com/industry-analysis/life-science-tools-market

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.